{"id":"W2947381343","doi":"10.1200/jco.2019.37.15_suppl.1041","title":"Interim results from the full population of the phase 3b CompLEEment-1 study of ribociclib (RIBO) plus letrozole (LET) in the treatment of HR+/HER2– advanced breast cancer (ABC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Population; Letrozole; Breast cancer; Interim analysis; Hazard ratio; Cancer; Chemotherapy regimen; Adverse effect; Oncology; Confidence interval; Clinical trial; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457689,0.0001876847,0.001613916,0.00006749228,0.00003610491,0.000003518536,0.000455544,0.0001357779,0.0001330577],"category_scores_gemma":[0.0003897708,0.00008398024,0.0004199955,0.0002484065,0.0002767206,0.0001045312,0.0000594989,0.0005077093,0.000001502798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004332351,"about_ca_system_score_gemma":0.0004911428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001979205,"about_ca_topic_score_gemma":0.002672599,"domain_scores_codex":[0.9949076,0.00102912,0.003064105,0.0002193963,0.0005809675,0.0001988503],"domain_scores_gemma":[0.9921175,0.002829481,0.003995105,0.0005991957,0.0003880209,0.00007069831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1268619,0.02619815,0.3752562,0.00004509062,0.001654747,0.00004382568,0.01290361,0.002739044,0.006205142,0.00004819662,0.0002115789,0.4478326],"study_design_scores_gemma":[0.08244193,0.02734023,0.8740312,0.0003359182,0.0004988083,0.0000484253,0.007352756,0.0002162113,0.0003057355,0.0001769752,0.007168313,0.00008350806],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898148,0.0007051009,0.00002607159,0.007250938,0.0009132257,0.001034898,0.0001434283,0.000003087707,0.0001084701],"genre_scores_gemma":[0.9983141,0.0003492466,0.0002510889,0.0005497081,0.0004513381,0.00001627738,0.000009662303,0.00001665691,0.00004193561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.498775,"threshold_uncertainty_score":0.3424615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1299282133590225,"score_gpt":0.5039471352598323,"score_spread":0.3740189219008098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}